Simply the best growth stocks in the FTSE 100?

Bilaal Mohamed reveals three often-overlooked companies from the FTSE 100 (INDEXFTSE: UKX) with exciting growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’ll be discussing the outlook for speciality pharmaceuticals firm Shire, global building materials business CRH, and support services group Babcock International. Could this trio of blue chips be the best available growth stocks from within the FTSE 100 (INDEXFTSE: UKX) today?

Better together

Fans of Shire (LSE: SHP) had plenty of reason to cheer this week as it announced strong interim results for the six months to the end of June. In fact, the company raised its full-year guidance after second quarter results revealed a forecast-beating 57% rise in sales. Shire also completed the $32bn acquisition of US-based rare disease drugs specialist Baxalta in June, and now expects operating cost synergies of $700m to be achieved by the third year following the deal.

The City is expecting great things from the group this year, with analysts talking about an impressive 86% rise in underlying earnings, followed by a further 19% improvement predicted for 2017. The Dublin-based group has a proven track record of earnings growth, and I feel next year’s earnings multiple of 13 doesn’t fully reflect the company’s outstanding growth prospects. In my opinion Shire offers plenty of upside potential for investors seeking capital growth within the pharmaceuticals sector.

Building an empire

Another FTSE 100 firm to lift its forecasts recently was building materials giant CRH (LSE: CRH). The company isn’t due to release it interim report for the first six months of the year until 25 August, but has indicated that it expects first-half earnings to be higher than previously expected as a result of exceptional trading in the latter part of Q2. The company now expects earnings to come in €100m higher at €1.1bn for the first half of 2016 – how’s that for an upgrade!

Shares in the Irish firm have certainly outperformed in recent months, gaining almost 30% in the six months since February, but I believe there’s plenty more to come. Indeed, market consensus suggests a 72% leap in profits for the full year to December, with a further 19% hike pencilled-in for 2017. This would leave the shares trading on a well-below-par earnings multiple of 15, and looking undervalued given the medium-term growth outlook.

A good start to the year

Meanwhile, the UK’s leading engineering support services group Babcock International (LSE: BAB) has stated that its long-term fundamentals remain unchanged despite uncertainty over the effects of Brexit, and says it remains confident of delivering continued growth. The new financial year has started well with 85% of projected revenue in place for FY2017, and 56% in place for FY2018.

The share price has experienced a strong pull-back since reaching all-time highs of £14 in 2014. I believe now could be a good time to grab a slice of the action with shares changing hands at below £10 and an undemanding P/E rating of just 11 for fiscal 2018.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Bilaal Mohamed has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

A brilliantly reliable FTSE 100 share I plan to never sell!

This FTSE-quoted share has raised dividends for more than 30 years on the spin! Here's why I plan to hold…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

This 7.7% yielding FTSE 250 stock is up 24% in a year! Have I missed the boat?

When a stock surges, sometimes it can be too late to buy shares and capitalise. Is that the case with…

Read more »

Investing Articles

£13,200 invested in this defensive stock bags me £1K of passive income!

Building a passive income stream is possible and this Fool breaks down one investment in a single stock that could…

Read more »

Investing Articles

I think the Rolls-Royce dividend is coming back – but when?

The Rolls-Royce dividend disappeared in 2020 and has not come back. But with the company performance improving, might it reappear?

Read more »

British Pennies on a Pound Note
Investing Articles

Should I snap up this penny share in March?

Our writer is considering penny shares to buy for his portfolio next month. Does this mining company merit a place…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Stock market bubble – or start of a bull run?

Christopher Ruane considers whether the surging NVIDIA share price could be symptomatic of a wider stock market bubble forming.

Read more »

Investing Articles

Buying 8,254 Aviva shares in an empty ISA would give me a £1,370 income in year one

Harvey Jones is tempted to add Aviva shares to his Stocks and Shares ISA this year. Today’s 7.37% yield isn't…

Read more »

Investing Articles

Is the tide turning for bank shares?

Bank shares are trading on stubbornly cheap-looking valuations yet business performance in the sector is broadly robust. Should our writer…

Read more »